Home › Trial NCT05479578
Cyclophosphamide and Dexamethasone for the Treatment of Metastatic Castration Resistant Prostate Cancer
- Trial IDNCT05479578
- StatusActive Not Recruiting
- PhasePhase 1
- Study typeInterventional
- SponsorRashmi Verma, MD
- Enrollment7
- Start date2022-06-29
- ConditionsCastration-Resistant Prostate Carcinoma · Metastatic Prostate Adenocarcinoma · Stage IVB Prostate Cancer American Joint Committee on Cancer (AJCC) V8
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.